Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Recursion Pharmaceuticals Inc Cl A (RXRX)

Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Recursion Pharmaceuticals: Q2 Earnings Snapshot AP - Wed Aug 5, 5:41AM CDT

Recursion Pharmaceuticals: Q2 Earnings Snapshot

RXRX : 3.50 (+13.27%)
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program GlobeNewswire - Wed Aug 5, 5:30AM CDT

Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated targets...

RXRX : 3.50 (+13.27%)
Recursion's AI Drug Discovery Timeline Gets Its Quarterly Reality Check Barchart - Tue Aug 4, 4:30PM CDT

Barchart Research What to Expect from RXRX Earnings RXRX Generated August 4, 2026 Current Price $3.31 EPS Estimate $$-0.23 Consensus Rating Moderate Buy Average Move 5.39% Recursion's AI Drug Discovery...

RXRX : 3.50 (+13.27%)
Recursion to Participate in Upcoming Investor Conferences GlobeNewswire - Tue Aug 4, 7:00AM CDT

Salt Lake City, UT, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation...

RXRX : 3.50 (+13.27%)
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules GlobeNewswire - Fri Jul 31, 3:30PM CDT

Salt Lake City, UT, July 31, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on July 27, 2026,...

RXRX : 3.50 (+13.27%)
Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th GlobeNewswire - Wed Jul 29, 7:30AM CDT

Salt Lake City, UT, July 29, 2026 (GLOBE NEWSWIRE) -- Salt Lake City, UT, July 29, 2026 (GLOBE NEWSWIRE) – Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically...

RXRX : 3.50 (+13.27%)
Businessman touching the brain working of Artificial Intelligence (AI) Automation by Suttiphong Chandaeng via Shutterstock
1 of the Most Interesting AI Stocks in the Market Isn’t a Tech Company Barchart - Tue Jun 23, 3:30PM CDT

Recursion Pharmaceuticals is trying to prove that AI’s next big winner can also come from biotech, and not just from the tech sector.

RXRX : 3.50 (+13.27%)
RHHBY : 58.2000 (+4.82%)
SNY : 45.83 (+1.91%)
Recursion to Participate in Upcoming Investor Conferences GlobeNewswire - Tue Jun 2, 7:00AM CDT

Salt Lake City, UT, June 02, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation...

RXRX : 3.50 (+13.27%)
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules GlobeNewswire - Fri May 29, 3:30PM CDT

Salt Lake City, UT, May 29, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on May 26, 2026, the...

RXRX : 3.50 (+13.27%)
MarketBeat.com
A Deep Dive Into NVIDIA’s Latest Portfolio Moves MarketBeat - Tue May 19, 1:05PM CDT

NVIDIA's latest 13F filing does not tell the story it seems to at first glance. The apparent divergence in its CoreWeave and Nebius holdings is a prime example.

NVDA : 217.56 (-0.99%)
CRWV : 90.87 (-2.47%)
GENB : 16.97 (+5.53%)
INTC : 92.80 (-4.02%)
SNPS : 401.24 (-0.78%)
COHR : 287.47 (-6.19%)
NBIS : 223.90 (-9.87%)
RXRX : 3.50 (+13.27%)
NOK : 10.13 (-2.50%)
LITE : 827.60 (-5.23%)
MRVL : 237.27 (+9.85%)

Barchart Exclusives

This High-Yield Exchange Stock Just Raised Its Dividend by Nearly 20% Barchart - Wed Aug 19, 6:30PM CDT
Cboe Global Markets raised its quarterly dividend by 19% to $0.86 per share on Aug. 13, marking the 16th consecutive year of increases, supported by strong options trading volumes and solid second-quarter results. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.